Jupiter Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$183K Buy
+16,371
New +$164K ﹤0.01% 540
2023
Q4
– Sell
-708,257
Closed -$6.64M – 544
2023
Q3
$6.64M Buy
708,257
+205,913
+41% +$2.94M 0.07% 233
2023
Q2
$12.3M Buy
502,344
+108,685
+28% +$2.73M 0.13% 191
2023
Q1
$9.15M Buy
+393,659
New +$10.1M 0.13% 184

Other funds holding VIR

Jupiter Asset Management's VIR Position: Q3 2026 in Review

Jupiter Asset Management opened a new position in Vir Biotechnology (VIR) in Q3 2026: 16,371 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #540 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in VIR as recently as Q3 2023.

Jupiter Asset Management first reported a position in VIR in Q1 2023 and has held it in 4 quarters since. The position peaked at $12.3M in Q2 2023. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Jupiter Asset Management held 16,371 shares of Vir Biotechnology worth $183K as of Q3 2026.
  • Vir Biotechnology was a new Jupiter Asset Management position in Q3 2026.
  • Vir Biotechnology made up ﹤0.01% of Jupiter Asset Management's portfolio in Q3 2026, its #540 holding.
  • Jupiter Asset Management first reported a position in Vir Biotechnology in Q1 2023 and has held it in 4 quarters since.
  • Jupiter Asset Management's Vir Biotechnology position peaked at $12.3M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.